Periodontal regeneration with 0.3 % basic fibroblast growth factor (FGF-2) for a patient with aggressive periodontitis: a case report

被引:5
|
作者
Yoshinuma, Naoto [1 ,2 ]
Koshi, Ryosuke [1 ,2 ]
Kawamoto, Kazuhiro [1 ]
Idesawa, Masataka [3 ]
Sugano, Naoyuki [1 ,2 ]
Sato, Shuichi [1 ,2 ]
机构
[1] Nihon Univ, Sch Dent, Dept Periodontol, Tokyo 1018310, Japan
[2] Nihon Univ, Sch Dent, Dent Res Ctr, Div Adv Dent Treatment, Tokyo 1018310, Japan
[3] Shunyokai Sakura Dent Off, Chiba, Japan
关键词
FGF-2; periodontal regeneration; aggressive periodontitis; clinical trial; TISSUE REGENERATION; DEFECTS; THERAPY; BFGF;
D O I
10.2334/josnusd.58.137
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
This case report describes the clinical efficacy of treatment with basic fibroblast growth factor (FGF-2) for periodontal regeneration. A patient with aggressive periodontitis participated in a clinical trial involving administration of 0.3% FGF-2 in comparison with a placebo control. To evaluate the efficacy of FGF-2, standardized radiographs were taken before surgery and at 12, 24, and 36 weeks after FGF-2 treatment. The rate of increase in alveolar bone height was 86.9% at 36 weeks. The 6-year postoperative radiograph showed significant development of alveolar bone in comparison with the first visit. FGF-2 treatment may be effective for periodontal regeneration in cases of aggressive periodontitis.
引用
收藏
页码:137 / 140
页数:4
相关论文
共 50 条
  • [41] Periodontal treatment in a patient with aggressive periodontitis and von Willebrand disease: a case report
    Miesbach, W.
    Eickholz, P.
    Himmer, K.
    Alesci, S.
    Wohlfeil, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1151 - 1151
  • [42] Overexpression in Escherichia coli and purification of human fibroblast growth factor (FGF-2)
    Gasparian, M. E.
    Elistratov, P. A.
    Drize, N. I.
    Nifontova, I. N.
    Dolgikh, D. A.
    Kirpichnikov, M. P.
    BIOCHEMISTRY-MOSCOW, 2009, 74 (02) : 221 - 225
  • [43] Overexpression in Escherichia coli and purification of human fibroblast growth factor (FGF-2)
    M. E. Gasparian
    P. A. Elistratov
    N. I. Drize
    I. N. Nifontova
    D. A. Dolgikh
    M. P. Kirpichnikov
    Biochemistry (Moscow), 2009, 74 : 221 - 225
  • [44] ABNORMAL BONE-GROWTH AND SELECTIVE TRANSLATIONAL REGULATION IN BASIC FIBROBLAST GROWTH-FACTOR (FGF-2) TRANSGENIC MICE
    COFFIN, JD
    FLORKIEWICZ, RZ
    NEUMANN, J
    MORTHOPKINS, T
    DORN, GW
    LIGHTFOOT, P
    GERMAN, R
    HOWLES, PN
    KIER, A
    OTOOLE, BA
    SASSE, J
    GONZALEZ, AM
    BAIRD, A
    DOETSCHMAN, T
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 (12) : 1861 - 1873
  • [45] The basic fibroblast growth factor (FGF-2) antisense RNA (GFG) is translated into a MutT-related protein in vivo
    Li, AW
    Too, CKL
    Murphy, PR
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 223 (01) : 19 - 23
  • [46] PURIFICATION AND CHARACTERIZATION OF THE 210-AMINO ACID RECOMBINANT BASIC FIBROBLAST GROWTH-FACTOR FORM (FGF-2)
    PATRY, V
    BUGLER, B
    AMALRIC, F
    PROME, JC
    PRATS, H
    FEBS LETTERS, 1994, 349 (01) : 23 - 28
  • [47] Basic fibroblast growth factor (FGF-2) induced transdifferentiation of retinal pigment epithelium: Generation of retinal neurons and glia
    Sakaguchi, DS
    Janick, LM
    Reh, TA
    DEVELOPMENTAL DYNAMICS, 1997, 209 (04) : 387 - 398
  • [48] Effects of basic fibroblast growth factor (FGF-2) on proliferation of human skin fibroblasts in type II diabetes mellitus
    Grazul-Bilska, AT
    Luthra, G
    Reynolds, LP
    Bilski, JJ
    Johnson, ML
    Adbullah, SA
    Redmer, DA
    Abdullah, KM
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2002, 110 (04) : 176 - 181
  • [49] Localization and regulation of basic fibroblast growth factor (FGF-2) and FGF receptor-1 in rat superior cervical ganglion after axotomy
    Klimaschewski, L
    Meisinger, C
    Grothe, C
    JOURNAL OF NEUROBIOLOGY, 1999, 38 (04): : 499 - 506
  • [50] Networking with fibrinogen: a prerequisite for fibroblast growth factor-2 (FGF-2)-stimulated tumor growth?
    Dahl, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (01) : 174 - 175